What are the risks and benefits of low-dose aspirin?

Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology. Investigators conducted the review because the overall balance between risks and benefits of taking aspirin has been unclear. The team pooled information from analyses of all relevant observational studies and…

Details

Certain personality traits may affect risk of ‘pre-dementia’

A study published in the Journal of the American Geriatrics Society examined five personality traits–neuroticism, extraversion, conscientiousness, agreeableness, and openness–and their links to pre-dementia conditions called motoric cognitive risk (MCR) and mild cognitive impairment (MCI) syndromes. Among 524 adults aged 65 years and older who were followed for a median of 3 years, 38 participants…

Details

ATS announces $500,000 COVID-19 crisis fund support from AstraZeneca

June 3, 2020 -Today, the American Thoracic Society (ATS) announced a $500,000 donation from AstraZeneca to the ATS COVID-19 Crisis Fund, launched to support the Society’s all-encompassing efforts to fight COVID-19. The Crisis Fund will help clinicians and scientists develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care…

Details

CEPI awards up to $14.1 million to IVI and Bharat Biotech to advance development of Chikungunya vaccine

June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India–CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of a Chikungunya vaccine. CEPI will provide the consortium with up to…

Details